Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.

"CONFLICT OF INTEREST STATEMENT J.H.C. received speaker's honoraria from Baxter Healthcare outside the submitted work. D.W.J. received consultancy fees, speaker's honoraria and research grants from Baxter Healthcare and Fresenius Medical Care, travel sponsorship from Amgen, consultancy fees from AstraZeneca and AWAK, research grants from National Health and Medical Research Council of Australia, speaker's honoraria from Ono and consultancy fees from Bayer outside the submitted work and is the current recipient of an Australian National Health and Medical Research Council (NHMRC) Leadership Level 3 Investigator Grant. Y.C. received speaker's honoraria and research grants from Baxter Healthcare and Fresenius Medical Care, research grants from National Health and Medical Research Council of Australia and is the current recipient of an Australian National Health and Medical Research Council Emerging Leadership Level 2 Investigator Grant and Advancing Queensland Health Fellowship. K.S. received speaker's honoraria from Baxter Healthcare and is on the medical advisory board of Fresenius Medical Care for Australia and New Zealand N.B. received consultancy fees from AstraZeneca and Baxter Healthcare and travel grants from Roche Pharmaceuticals and Amgen outside the submitted work."

"FUNDING None."